Pharsight

NOVARTIS PHARMA GMBH PATENTS FACING OPPOSITIONS

Top patents of NOVARTIS PHARMA GMBH facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2228064B1 11 Dec, 2019 Pharmaceutical composition containing glycopyrrolate and a beta2 adrenoceptor agonist May, 2025 10
EP2269603B1 20 May, 2015 Treatment of breast tumors with a rapamycin derivative in combination with exemestane Feb, 2022 9